Our team is comprised of physicians who are board-certified in Hematology, Medical Oncology, and Internal Medicine, oncology nurse specialists, lab and support staff. Our physicians care for patients with hematologic (blood) and/or oncologic (cancer) conditions. When necessary, our patients are admitted to Bryn Mawr Hospital. Our expanding practice currently sees an average of 100-150 new patients per month, and the multidisciplinary Bryn Mawr Hospital Cancer Program cares for nearly 1300 new patients annually. Together we provide the full range of hematology and oncology services with a very “patient-oriented” philosophy.

Our four board-certified physicians have contributed to the medical literature, and are very active in clinical research. Each physician currently sees patients with a variety of blood-related and cancer-related health conditions. Our highly trained clinical physician extenders are experienced in the care of hematology/oncology patients, and are an integral part of our team.



  • Bryn Mawr Medical Arts Pavilion
  • 825 Old Lancaster Road
  • Suite 440
  • Bryn Mawr, PA 19010
  • Phone: (610) 525-4511
  • Fax: (610) 525-8561


Important Forms:
We encourage new patients to complete the forms enclosed in our new patient packets prior to their appointment. Please bring these forms to your consultation, along with any radiology studies and reports, pathology reports and slides, and other medical records from outside hospitals or offices. We can access records from hospitals of Main Line Health system, and will have them ready for your visit here.

Clinical Trials
Physicians in our department are passionate about clinical research.  We are a part of the Main Line Health Community Clinical Oncology Program (CCOP), and will work with you to find the best options available for your care, including discussing participation in clinical trials (if applicable to your care).  Additional information about clinical trials and Main Line CCOP may be found here:
Clinical Trials Home Page-National Cancer Institute
Clinical Trials for Cancer – Main Line Health
Main Line Health IRB